Virpax Pharmaceuticals, Inc. (VRPX)
OTCMKTS
· Delayed Price · Currency is USD
0.2400
+0.0080 (3.45%)
May 13, 2025, 3:42 PM EDT
Virpax Pharmaceuticals Market Cap
Virpax Pharmaceuticals has a market cap or net worth of $336.47 thousand as of May 13, 2025. Its market cap has decreased by -90.16% in one year.
Market Cap
336.47K
Enterprise Value
-1.18M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.24
Market Cap Chart
Since February 17, 2021, Virpax Pharmaceuticals's market cap has decreased from 32.29M to 336.47K, a decrease of -98.96%. That is a compound annual growth rate of -65.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 246.50K | -86.72% |
| Dec 31, 2024 | 1.86M | -50.48% |
| Dec 29, 2023 | 3.75M | -48.56% |
| Dec 30, 2022 | 7.29M | -81.86% |
| Dec 31, 2021 | 40.18M | 24.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.64B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 729.62M |
| Tian'an Technology Group | 568.98M |
| CytoDyn | 497.14M |
| Glass House Brands | 478.11M |
| Elite Pharmaceuticals | 468.54M |
| Northwest Biotherapeutics | 395.18M |